North Fitzroy, Australia

Mary Louise Garcia

This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: The Macfarlane Burnet Institute for Medical Research and Public Health Limited, Hepgenics Pty Ltd.. Active years: 2010-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mary Louise Garcia. Retrieved from https://idiyas.com/inventor/mary-louise-garcia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 20(Granted Patents)


Location History:

  • Fitzroy, AU (2010)
  • North Fitzroy, AU (2013)

Company Filing History:


Years Active: 2010-2024

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Mary Louise Garcia: Innovator in Diagnostic and Therapeutic Protocols

Introduction

Mary Louise Garcia is a distinguished inventor based in North Fitzroy, Australia. She has made significant contributions to the fields of diagnostics and therapeutics, holding a total of 3 patents. Her innovative work focuses on antibody capture processes and methods for monitoring cellular components in biological samples.

Latest Patents

One of her latest patents is titled "Diagnostic, prognostic, therapeutic and screening protocols." This invention describes an antibody capture process that involves obtaining a biological sample containing antibodies and contacting it with recombinant pIgR or a dIgA-binding variant. This process forms a pIgR-dIgA complex, which can be assessed to determine the level of the complex or its interaction with specific antigens. Additionally, she has developed a method for determining gut wall integrity by comparing the levels of SIgA to dIgA in test subjects against control subjects. Her patent also includes kits that utilize recombinant pIgR for capturing or detecting dIgA and/or IgM.

Another notable patent is "Method of diagnosis and kit therefor," which provides kits and methods for detecting or monitoring the number of cells in a sample. This method involves using a cell surface associated protein (CSAP) and a CSAP-binding agent to evaluate the presence of bound CSAP in the sample. The kit comprises a chromatographic device and is designed to enhance the accuracy of cellular analysis.

Career Highlights

Mary Louise Garcia has worked with reputable organizations, including the Macfarlane Burnet Institute for Medical Research and Public Health Limited and Hepgenics Pty Ltd. Her work in these institutions has allowed her to advance her research and contribute to significant medical innovations.

Collaborations

Throughout her career, she has collaborated with notable professionals, including David Andrew Anderson and Alan Lee Landay. These collaborations have enriched her research and expanded the impact of her inventions.

Conclusion

Mary Louise Garcia is a pioneering inventor whose work in diagnostic and therapeutic protocols has the potential to transform medical practices. Her innovative patents and collaborations highlight her commitment to advancing healthcare through scientific research and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…